{
  "trial_id": "NCT00371293",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Moderate to severe OSA (as defined by an apnea-hypopnea index [AHI] score greater than 15 events per hour)",
      "label": "met"
    },
    {
      "criterion": "Body mass index greater than 30 kg/m",
      "label": "met"
    },
    {
      "criterion": "Baseline CRP greater than 1.0 mg/dL",
      "label": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Predominant central sleep apnea",
      "label": "not_met"
    },
    {
      "criterion": "Type 1 Diabetes",
      "label": "not_met"
    },
    {
      "criterion": "Type 2 Diabetes associated with either: (a) unstable anti-diabetic therapy; (b) Hemoglobin A1C levels > 7%; (c) Inability to perform home blood glucose monitoring (fingerstick checks).",
      "label": "not_met"
    },
    {
      "criterion": "Requires use of supplemental oxygen",
      "label": "unknown"
    }
  ],
  "notes": "Patient has COPD, OSA, and obesity hypoventilation syndrome. Daughter reports increased agitation and altered mental status with hypoxia and O2 sats 70s on BipAp.",
  "_meta": {
    "topic_id": "14",
    "trial_id": "NCT00371293",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}